ISPC
iSpecimen Inc. (ISPC) SWOT Analysis Analysis (2026)
No material changes this month.
Overall Score
Strengths
Low leverage and modest debt burden, with debt-to-equity at 0.14 and debt-to-assets at 0.03.
Cash per share of 3.17 provides some near-term liquidity support.
Valuation remains depressed, with price-to-sales at 0.46 and price-to-book at 1.23.
Weaknesses
Profitability remains deeply negative, with net margin at -24.5% and operating margin at -20.2%.
Returns on capital are severely negative, including ROE at -5.24 and ROIC at -4.76.
Liquidity is tight, with current ratio at 0.82 and working capital at -992,538.
Opportunities
A turnaround in operating efficiency could matter given the very low asset turnover of 0.06 and negative cash conversion cycle.
If revenue stabilizes, the low sales multiple could offer upside from current depressed valuation.
Threats
Persistent cash burn is a major risk, with free cash flow per share at -5.74 and operating cash flow per share at -5.02.
Negative gross margin of -151.5% suggests severe cost or pricing pressure.
The company’s negative enterprise value and weak solvency metrics indicate ongoing financial distress risk.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on iSpecimen Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
